About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Chicago | 134 Studies

Clinical Trials Kidney DiseaseChicago

Kidney Disease Clinical Trials in Chicago

Find 134 clinical trials for kidney disease near Chicago, Illinois. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 134 trials

CompletedThe COMBINE Study: The CKD Optimal Management With BInders and NicotinamidEThe COMBINE clinical trial is a pilot study evaluating the effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor 23 (FGF23) in patients…NCT02258074·San Diego, California and 6 others CompletedRepeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D InsufficiencyAn Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol…NCT03588884·Garden Grove, California and 2 others CompletedIron Deficiency and FGF23 Regulation in CKD and HFThis study investigates the effects of intravenous (IV) iron sucrose therapy on blood levels of Fibroblast Growth Factor 23 (FGF23, a protein that regulates the amount of…NCT03106298·Chicago, Illinois TerminatedEfficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisThe primary objective was to evaluate the efficacy of cinacalcet for reducing the plasma intact parathyroid hormone (iPTH) level by ≥ 30%.NCT02138838·Los Angeles, California and 59 others

Kidney Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTrial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseThis study assesses the effects of bardoxolone methyl (RTA 402) in patients with type 2 diabetes and chronic kidney disease.NCT00811889·Birmingham, Alabama and 41 others

RecruitingTargeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, EmpagliflozinSickle cell anemia (SCA) is an inherited red blood disorder. The kidneys are among the most commonly affected organ systems in SCA.NCT07175051·Chicago, Illinois

CompletedA Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinThe purpose of the study is to determine the long-term safety in treatment-emergent adverse events (TEAEs) of intravenous (IV) administration of Epoetin Hospira for maintenance of…NCT01628107·Azusa, California and 109 others

CompletedA Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more.NCT06077864·Birmingham, Alabama and 539 others

CompletedPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareUnderstudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug…NCT01431326·Anchorage, Alaska and 51 others

CompletedA Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseThe researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 diabetes.NCT03819153·Tuscumbia, Alabama and 412 others

CompletedEMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on top of standard of care in…NCT03594110·Huntsville, Alabama and 239 others

CompletedSafety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisThe purpose of this study was to evaluate the safety and efficacy of peginesatide for the treatment of anemia in participants with chronic kidney disease, who are not on dialysis…NCT00598442·Phoenix, Arizona and 63 others

CompletedPharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised SubjectsThe goal of this clinical trial was to compare transdermal glomerular filtration rate (tGFR) to plasma-derived indexed (to body surface area; BSA) GFR (nGFR) using MB-102…NCT05425719·Edgewater, Florida and 7 others

CompletedA Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt NephropathyPF-00489791 is an inhibitor of phosphodiesterase type 5.NCT01200394·Huntsville, Alabama and 159 others

CompletedFolic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of…NCT00064753·Birmingham, Alabama and 29 others

CompletedExercise Training and Cognitive Function in Kidney DiseaseChronic kidney disease (CKD), affects over 45% of all individuals over 70 years of age.NCT03197038·Chicago, Illinois

CompletedStrategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney DiseaseA phase 3, multicenter, randomized, double-blind, parallel group study.NCT01652872·Anniston, Alabama and 248 others

RecruitingA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired…NCT07662135·Sun City, Arizona and 185 others

Active not recruitingStudy to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)This is a Phase III, randomised, multicentre, double-blinded study to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone…NCT06087835·Huntsville, Alabama and 295 others

CompletedA Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney DiseaseThis study is open to adults who have kidney disease that is not caused by diabetes.NCT04736628·Canyon Country, California and 109 others

PreviousPage 2 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia